Duke Adult Sickle Cell Program — Durham, North Carolina

Duke Adult Sickle Cell Program is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Duke Adult Sickle Cell Program has participated in 1 clinical trials.

Therapeutic areas: Sickle Cell Disease, COVID-19 Vaccine, Vaccine Hesitancy.

Sponsors: Duke University.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Adult Sickle Cell Program?

Duke Adult Sickle Cell Program has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Adult Sickle Cell Program conducted?

Duke Adult Sickle Cell Program has 1 clinical trials on record. Their work covers Sickle Cell Disease, COVID-19 Vaccine, Vaccine Hesitancy.

Is Duke Adult Sickle Cell Program accredited by Crixeo Health?

Duke Adult Sickle Cell Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Adult Sickle Cell Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.